DIA 2019 Call for Topics
Deadline: July 6 at 11:59PM
DIA and the Annual Meeting Program Committee (AMPC) want to hear from you! Submit a topic during our DIA 2019 Call for Topics. This is your opportunity to share your suggestions on thought provoking, trending, and timely topics that are important to you, your colleagues, and the DIA community.
Topic submissions will be reviewed by the AMPC to assist with the content development and strategy for DIA 2019. Submission of a topic is not in any way related to a speaking role at DIA 2019. An open Call for Abstracts will be available in August to solicit sessions and presentations for DIA 2019.
Have Questions? Check out our FAQs on how to submit your topic and/or abstract and more!
Below are four different examples of a suggested topic:
- Considerations for pre-launch healthcare communication with payers
- Best Practices for implementing the ISO IDMP standards
- Recent regulatory pathways and policies related to personalized medicine in the US
- Effective strategies for collaborations among industry, academia, and health authorities
Learn more about the content development process for DIA 2019 and submission process for this Call and those in the future.
View tracks and included topics areas
Global and US Advertising and Promotional regulations and laws, regulatory operation best practices, regulatory intelligence, developments in regulatory science, eSubmissions, regulatory document management, biosimilars, combination products, companion diagnostics, compliance
Safety and Pharmacovigilance
Safety/Pharmacovigilance best practices guideline updates, benefit-risk assessment, risk-based monitoring, document management, biosimilars, post-market safety considerations, combination products, companion diagnostics, compliance, ICH(E), audit/inspection
Clinical Trials and Clinical Operations
Personalized medicine, gene editing, clinical trial recruitment and retention, patient engagement, site management, specific therapeutic areas, endpoints/COA’s (Patient-reported outcome (PRO) measures, clinician-reported outcome (ClinRO) measures, observer-reported outcome (ObsRO) measures, and performance outcome (PerfO) measures, COA compendium, telemedicine, eHealth, mobile health, wearables, eHR, clinical trial diversity, collaborations, stem cells, regenerative therapies, gene therapies, etc., ICH(E); GCP, audit/inspection
Data/ Data Standards
Informatics, data standards and standardization, data management, data quality, data systems, data integration, compliance, bioethics, security, data privacy, transparency, big data, data sources (eHR)
Medical Affairs and Scientific Communication
Medical information, Medical Science Liaison, medical writing, medical affairs roles throughout product lifecycle, stakeholder management, advisory boards, compliance
ICH Q, CMC, GMP, audit/inspection, compliance
Adaptive design, Bayesian statistics, informatics, bioinformatics, analytic standards, data visualization
Project Management and Strategic Planning
Portfolio management, project management, transformative partnerships, funding, global compliance, product lifecycle planning, global commercialization considerations
Preclinical Development and Early Phase Clinical Development
Personalized medicine, gene editing, clinical trial data disclosure, clinical trial data disclosure, collaborations, bioethics, compliance, stem cells, regenerative therapies, gene therapies, ICH (S), study endpoints
Value and Access
Comparative effectiveness research, health technology assessment, real-world outcomes, value-based healthcare, drug pricing, reimbursement and access, commercialization, drug product lifecycle considerations